Key facts
- It has raised $14.5M; the latest was Later Stage VC ($14.5M) in Mar 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, Shunwei Capital, Frees Fund, Optics Valley Industry Investment, Xi'an Finance Investment Management — 12 tracked in total.
- Status: Privately Held (backing).
Investors
12+- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for NeuroDome
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroDome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroDome
Developer and manufacturer of minimally invasive surgical equipment designed for neurosurgery. With non-invasive deep brain neuromodulation technology and other related technologies, the company's solutions include wearable medical instruments, medical imaging technology and medical information systems, enabling medical users to reduce the risk of neurosurgery.
- Sector
- Healthcare
- HQ
- Xi'an, China
- Founded
- 2019
- Employees
- 1
- Website
- neurodome-med.com/
- Ownership
- Privately Held (backing)
NeuroDome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroDome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroDome in its N-PORT filings yet. We sweep new filings monthly.